YOLFTbeta
Roche Holding AG

Roche Holding AG

ROP · SW · Healthcare / Drug Manufacturers - General

379.7CHF+8.80 (+2.37%)

Price History

Full chart

Market Stats

Previous Close370.9
Open373.9
Day Range370.7 – 379.7
52-Week Range250.53 – 375.8
Volume1.41M
Market Cap275.44B
P/E (TTM)22.57
Forward P/E16.50
EPS15.32
Dividend Yield2.81%
Beta0.35
50-Day Avg359.59
200-Day Avg339.25

About

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEODr. Thomas Schinecker
  • Employees103.25K
  • HeadquartersGrenzacherstrasse 124, Basel, Switzerland, 4070, Switzerland
  • Websitehttps://www.roche.com

Leadership

  • Dr. Severin Schwan Ph.D.Executive Chairman · b. 1967
  • Dr. Thomas SchineckerGroup Chief Executive Officer · b. 1975
  • Dr. Alan HippeChief Financial Officer · b. 1967
  • Ms. Wafaa MamilliChief Digital & Technology Officer · b. 1967
  • Dr. Bruno EschliHead of Investor Relations
  • Ms. Claudia BockstiegelGeneral Counsel · b. 1964
  • Dr. Nina Schwab-HautzingerHead of Group Communications · b. 1975
  • Ms. Maria Cristina A. WilburChief People Officer · b. 1967
  • Dr. Nicolas DunantHead of Group Media Relations
  • Mr. Boris L. ZaitraHead of Corporate Business Development · b. 1972

Financials

Income Statement

Line item1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue24.66B27.57B28.67B29.16B29.73B31.22B31.27B35.51B42.04B46.13B45.62B49.05B47.47B42.53B45.50B48.61B49.87B50.40B52.64B55.75B59.50B63.75B58.32B62.80B65.81B60.44B62.40B61.52B
Cost of Revenue7.90B8.87B9.16B8.34B8.43B8.31B7.18B9.30B10.62B13.74B13.66B14.62B13.29B11.94B12.18B12.38B12.98B14.25B15.08B15.89B16.52B17.39B16.35B19.70B17.94B16.36B16.28B16.28B
Gross Profit16.76B18.69B19.51B20.82B21.29B22.91B24.09B26.21B31.43B32.39B31.96B34.44B34.18B30.59B33.32B36.23B36.89B36.16B37.56B39.86B42.98B46.37B41.97B43.10B47.88B44.08B46.11B45.23B
Operating Income4.37B6.42B7.13B3.25B1.33B5.59B8.98B8.67B11.73B14.47B13.92B12.28B13.49B13.45B14.13B16.61B16.51B15.46B16.85B17.30B18.92B21.03B17.73B18.16B17.48B15.39B13.42B19.26B
EBITDA6.44B8.87B27.57B4.80B2.85B7.10B10.58B11.80B15.38B18.13B17.02B14.71B15.66B15.72B16.01B18.15B19.13B19.05B17.66B16.74B18.34B21.56B22.97B22.19B20.80B18.41B16.62B22.66B
Net Income4.39B5.76B8.65B3.70B-4.03B3.07B6.64B6.73B7.88B9.76B8.97B7.78B8.67B9.34B9.54B11.16B9.33B8.86B9.58B8.63B10.50B13.50B14.29B13.93B12.42B11.50B8.28B12.88B
R&D3.41B3.78B3.95B3.89B4.26B4.77B5.09B5.71B6.59B8.38B8.85B9.87B10.03B8.33B9.55B9.27B9.89B9.58B11.53B11.29B12.09B12.77B12.15B14.80B15.22B14.20B15.30B13.35B
Interest Expense----4.52B1.08B-326.00M315.00M281.00M214.00M2.44B2.55B2.01B2.00B1.33B946.00M885.00M707.00M598.00M605.00M620.00M438.00M341.00M608.00M828.00M1.25B1.35B

Balance Sheet

Line item1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets55.88B70.43B69.53B75.29B63.99B59.49B58.08B69.36B74.41B78.18B76.09B74.56B61.02B61.58B64.81B62.17B75.54B75.76B76.82B76.68B78.52B83.09B86.14B92.32B88.15B90.47B101.80B100.70B
Total Liabilities33.06B40.43B37.50B41.42B38.22B30.32B24.78B27.62B27.60B24.88B22.27B65.15B49.36B47.09B48.08B40.93B53.98B52.46B50.42B47.67B48.15B47.22B46.37B63.97B56.14B57.20B65.64B62.82B
Total Equity21.67B26.95B27.61B28.97B20.81B23.57B28.22B34.92B39.44B45.35B44.48B7.37B9.47B12.10B14.49B19.29B19.59B20.98B23.91B26.44B27.62B32.75B36.34B24.49B27.99B29.32B31.77B33.80B
Cash1.98B2.05B2.56B3.14B3.43B5.28B2.60B4.23B3.21B3.75B4.92B2.44B1.84B3.85B4.53B4.00B3.74B3.73B4.16B4.72B6.68B6.08B5.73B6.85B4.99B5.38B6.97B5.58B
Total Debt20.11B24.32B21.62B23.73B22.35B15.29B8.96B9.67B8.24B6.87B4.09B42.42B30.06B26.85B24.59B18.64B25.71B23.25B22.36B18.96B18.77B15.58B15.41B32.55B26.54B30.78B36.35B33.19B
Net Debt18.12B22.27B19.06B20.59B18.92B10.01B6.36B5.44B5.03B3.11B-826.00M39.97B28.22B23.00B20.06B14.64B21.97B19.52B18.19B14.24B12.09B9.51B9.68B25.70B21.55B25.41B29.38B27.61B

Cash Flow

Line item1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.62B1.73B3.92B5.09B982.00M7.25B7.33B9.97B10.33B11.73B12.18B16.88B14.34B12.95B15.01B15.77B15.93B15.25B15.00B18.02B19.98B22.39B18.16B20.57B17.89B16.09B20.09B17.83B
Investing Cash Flow-7.92B-867.00M-832.00M-3.70B3.54B1.56B-2.02B-5.69B-7.45B-5.79B-1.72B-2.91B3.53B-353.00M-4.51B-1.30B-12.00B-4.28B-4.51B-6.46B-7.20B-8.63B-9.08B-6.55B-3.57B-10.64B-11.39B-8.71B
Financing Cash Flow3.99B-895.00M-2.54B-824.00M-3.94B-6.75B-7.86B-2.78B-3.71B-5.27B-9.44B-14.77B-18.43B-10.72B-9.69B-14.67B-3.96B-10.51B-10.07B-11.12B-10.69B-14.17B-9.24B-12.70B-15.72B-4.24B-6.82B-10.18B
Capital Expenditure2.28B2.41B2.40B2.14B2.14B2.49B2.54B3.67B4.15B4.46B3.56B3.22B3.01B2.21B2.41B2.45B2.97B3.47B4.14B3.51B4.04B3.50B6.69B4.55B4.55B4.65B5.01B3.75B
Free Cash Flow1.34B-686.00M1.51B2.95B-1.16B4.76B4.80B6.31B6.17B7.26B8.62B13.66B11.33B10.75B12.60B13.32B12.96B11.78B10.86B14.52B15.94B18.88B11.47B16.02B13.34B11.45B15.09B14.08B
Dividends Paid1.52B1.44B1.74B1.90B1.79B1.75B1.97B1.98B2.26B3.03B4.05B4.39B5.26B5.74B5.89B6.36B6.72B6.95B7.04B7.14B7.25B7.45B7.70B7.77B7.45B7.59B7.65B8.38B

Earnings

Report DateOct 21, 2008Jul 22, 2010Oct 14, 2010Feb 2, 2011Jul 21, 2016Jul 21, 2021Jan 28, 2027
EPS Estimate0.816.89-6.127.5410.24-
EPS Actual2.086.592.042.042.893.49-
Surprise156.79%-4.35%--66.67%-61.67%-65.92%-
TimingPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market

Key Statistics & Ratios

Market Cap275.44B
Enterprise Value312.74B
Trailing P/E22.57
Forward P/E16.50
PEG Ratio1.66
Price / Sales4.37
Price / Book8.85
EPS15.32
Book Value41.03
Revenue (TTM)62.96B
Gross Profit (TTM)46.69B
EBITDA23.96B
Profit Margin19.60%
Operating Margin36.20%
Return on Equity38.11%
Return on Assets13.51%
Shares Outstanding690.07M
Shares Float654.09M
Beta0.35
Dividend Yield2.81%
Dividend Rate9.8
Payout Ratio63.93%

Dividends

20261×
9.80Mar 12, 2026
20251×
9.70Mar 27, 2025
20241×
9.60Mar 14, 2024
20231×
9.50Mar 16, 2023
20221×
9.30Mar 17, 2022
20211×
9.10Mar 18, 2021
20201×
9.00Mar 19, 2020
20191×
8.70Mar 7, 2019
20181×
8.30Mar 15, 2018
20171×
8.20Mar 16, 2017
20161×
8.10Mar 3, 2016
20151×
8.00Mar 5, 2015
20141×
7.80Mar 6, 2014
20131×
7.35Mar 7, 2013
20121×
6.80Mar 8, 2012
20111×
6.60Mar 3, 2011
20101×
6.00Mar 4, 2010
20091×
5.00Mar 16, 2009
20081×
4.60Mar 7, 2008
20071×
3.40Mar 8, 2007
20061×
2.50Mar 2, 2006
20051×
2.00Mar 3, 2005
20041×
1.65Apr 13, 2004
20031×
1.45Apr 4, 2003

Stock Splits

  • May 4, 2001100:1